H. Lundbeck A/S (HLBBF)
OTCMKTS · Delayed Price · Currency is USD
7.21
-0.29 (-3.87%)
At close: Sep 30, 2025
H. Lundbeck Market Cap
H. Lundbeck has a market cap or net worth of $6.78 billion as of October 15, 2025. Its market cap has increased by 6.34% in one year.
Market Cap
6.78B
Enterprise Value
8.49B
Revenue
3.70B
Ranking
n/a
PE Ratio
12.35
Stock Price
$7.21
Market Cap Chart
Since June 10, 2022, H. Lundbeck's market cap has increased from 4.54B to 6.78B, an increase of 49.30%. That is a compound annual growth rate of 12.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 15, 2025 | 6.78B | 23.51% |
| Dec 30, 2024 | 5.49B | 16.62% |
| Dec 29, 2023 | 4.70B | 28.73% |
| Dec 30, 2022 | 3.65B | -19.48% |
| Jun 10, 2022 | 4.54B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Glass House Brands | 694.90M |
| Elite Pharmaceuticals | 673.15M |
| Veradigm | 517.28M |
| Nika Pharmaceuticals | 495.49M |
| Northwest Biotherapeutics | 356.04M |
| CytoDyn | 334.34M |
| American Oncology Network | 283.44M |
| Silence Therapeutics | 259.79M |